Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Meihua International Medical Technologies Co., Ltd. (MHUA) Stock Forecast & Price Prediction China | NASDAQ | Healthcare | Medical Instruments & Supplies
$0.38
+0.00 (0.00%)10 Quality Stocks Worth Considering Now
Researching Meihua (MHUA) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MHUA and similar high-potential opportunities.
MHUA has shown a year-to-date change of 11.8% and a 1-year change of -41.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MHUA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MHUA.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Meihua based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Meihua International Medical Technologies Co., Ltd. has a market capitalization of $12.16M with a P/E ratio of 1.0x. The company generates $96.91M in trailing twelve-month revenue with a 11.2% profit margin.
Revenue growth is +5.4% quarter-over-quarter, while maintaining an operating margin of +16.3% and return on equity of +7.1%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Designs and manufactures medical devices.
The company generates revenue by designing, manufacturing, and distributing a range of medical devices, including essential medical equipment such as syringes and infusion sets. By focusing on quality and innovation, it caters to hospitals, clinics, and healthcare providers globally, ensuring a steady demand for its products.
Meihua International emphasizes cutting-edge technology and strict quality control, which enhances patient care and meets the growing demand for reliable healthcare solutions. Its established distribution network and commitment to innovation position it as a key player in the evolving healthcare sector.
Healthcare
Medical Instruments & Supplies
619
Mr. Wang Xin
China
2022
Meihua International Medical Technologies (Nasdaq: MHUA) reported its financial results for FY 2024, ending December 31. The company specializes in disposable medical devices.
Meihua International's financial results can indicate its growth potential and market position, affecting investor sentiment and stock performance in the medical device sector.
Meihua International Medical Technologies (MHUA) announced on October 3, 2024, that it has regained compliance with Nasdaq's minimum bid price requirement.
Meihua International's compliance with Nasdaq's minimum bid price requirement can boost investor confidence, potentially stabilizing its stock price and attracting new investment.
Meihua International Medical Technologies Co., Ltd. is based in Yangzhou, China, and has made a news announcement on September 20, 2024. Further details are not provided.
The mention of Meihua International suggests potential developments in the healthcare sector, which could impact stock prices and investment strategies in medical technologies.
Meihua International Medical Technologies (Nasdaq: MHUA) will have CEO Xin Wang present recent corporate developments at a LIVE! event in Yangzhou, China, on August 26, 2024.
Meihua's CEO presentation could signal strategic developments, affecting investor sentiment and stock performance based on insights into corporate direction and market positioning.
Meihua International Medical Technologies (Nasdaq: MHUA) announced its NT-2000 system aided the world's second 5G remote robot-assisted lobectomy, highlighting advancements in their surgical technology.
The successful use of Meihua's NT-2000 system in a cutting-edge surgery highlights its innovation and potential growth in the telemedicine market, influencing investor sentiment and stock performance.
Meihua International Medical Technologies (Nasdaq: MHUA) announced a $3 million share repurchase program for its outstanding ordinary shares, approved by its board of directors.
Meihua's $3 million share repurchase program signals confidence in the company's value, potentially boosting share prices and demonstrating commitment to returning capital to shareholders.
Analyst forecasts for Meihua International Medical Technologies Co., Ltd. (MHUA) are not currently available. The stock is trading at $0.38.
Analyst ratings for MHUA are not currently available. The stock is currently trading at $0.38. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MHUA are not currently available. The stock is trading at $0.38.
The company generates revenue by designing, manufacturing, and distributing a range of medical devices, including essential medical equipment such as syringes and infusion sets. By focusing on quality and innovation, it caters to hospitals, clinics, and healthcare providers globally, ensuring a steady demand for its products.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $0.38.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $0.38.
Analyst ratings for MHUA are not currently available. The stock is trading at $0.38.
Stock price projections, including those for Meihua International Medical Technologies Co., Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.